Fosdenopterin: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Fosdenopterin. Educational only — not medical advice.

Labeled uses

NULIBRY is indicated to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A.

Source: FDA labeling via NIH DailyMed (set 736aeea3…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.